Home

Mainz Biomed N.V. - Ordinary Shares (MYNZ)

4.3650
-0.3650 (-7.72%)

Mainz Biomed N.V. is a biotechnology company focused on developing innovative molecular diagnostics and therapeutics for the early detection and treatment of various cancers

The company specializes in harnessing advanced biomarkers and genetic testing to empower healthcare providers and patients with accurate insights into disease risks and treatment options. By advancing personalized medicine and exploring novel diagnostic solutions, Mainz Biomed aims to enhance patient outcomes and improve the overall approach to cancer management.

SummaryNewsPress ReleasesChartHistoricalFAQ
Created with Highcharts 11.4.8ZoomView 1 month1mView 3 months3mView 6 months6mView year to dateYTDView 1 year1yView allAll1 Nov 202114 Mar 2025All ▾Jan '22Apr '22Jul '22Oct '22Jan '23Jul '23Oct '23Jan '24Apr '24Jul '24Oct '24Jan '25Jan '22Jan '22May '22May '22Sep '22Sep '22Jan '23Jan '23Sep '23Sep '23Jan '24Jan '24May '24May '24Sep '24Sep '24Jan '25Jan '2502468101214161820222426283032025M50M75MHighcharts.com